| abstract |
The present invention provides an aqueous acidic formulation suitable for use in the manufacture of a pharmaceutically acceptable fluorocarbon-binding peptide formulation, the aqueous formulation comprising a first fluorocarbon-binding peptide and binding to the fluorocarbon Peptides are 20 or more amino acid residues in length, contain at least 50% hydrophobic amino acid residues, and have an isoelectric point of 7 or more; And the fluorocarbon-binding peptide is present in micelles. |